IVD in colon cancer
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/27977
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Group A (control): chemotherapy (QT) FOLFOX OR CAPEOX, (intravenous administration) + placebo, in the same way as group B.
Group B (experimental): FOLFOX or CAPEOX chemotherapy, (intravenous administration), + Del-Immune V (DIV). The QT will be administered according to the established scheme and the DIV will be administered 1 capsule (dose) every 12 hours, orally, from 15 days before starting the chemo treatment until 15 days later.
Treatment for both groups will be administered continuously for 29 weeks from patient enrollment.;Dietary Supplements ;Placebos;Administration, Oral ;Administration, Intravenous ;Metabiotic Del-Immune V
Primary outcome(s): Inflammatory biomarker levels. IL-6 (will be measured in PG/ML), C-reactive protein (will be measured in mg/L), CEA tumor marker (will be measured in ng/mL). Measurement time: basal, 15 days, week 12, week 24.
Study Design: Allocation: Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment
创建时间：
2022-12-15
